Sovereign-Anchored M&A
Key Focus Areas
- Strategic minority rounds with sovereign anchors (PIF, Mubadala, ADIO, ADQ)
- Cross-border M&A involving Gulf strategic acquirers
- Joint ventures with Saudi or Emirati industrial holdings
- Listed-company partial sale or strategic stake placement
We advise European corporates and US scale-ups on capital operations where a Gulf sovereign or strategic investor takes a meaningful position. Our role spans the full transaction: anchor identification, term sheet negotiation, governance structuring, regulatory navigation, and SPA execution alongside top-tier global counsel.
Scale-up Fundraising
We support European deeptech, biotech and defense-tech scale-ups in raising Series A to C rounds with a Gulf institutional anchor — typically as a complement to European LP support. Our deal flow includes biotech rare disease, semiconductor, energy, and dual-use technology.
- Investor mapping and prioritization (sovereigns, family offices, regional VCs)
- Pitch positioning and dataroom support
- Roadshow execution in Riyadh, Abu Dhabi, Doha, Manama
- Term sheet negotiation and closing support
GCC Workshop Programme
Our flagship programme for European private equity funds. A two- to three-day structured engagement in the Gulf, designed around the fund's portfolio companies and LP development needs. We use our institutional access to bring the right Gulf decision-makers into the room — not the usual suspects.
Pre-engagement portfolio mapping
(typically 4-6 portfolio companies prioritized)
Curated meetings with sovereigns, strategic corporates, and family offices
LP development support
(Sanabil, Mubadala Capital, ADQ, regional family offices)
Post-engagement deal-flow facilitation
Healthcare Public Affairs
We advise pharmaceutical, medtech and hospital groups on their long-term strategic positioning in Saudi Arabia, the UAE and Qatar. Our advantage is direct: 5 years as advisor to the Saudi Ministers for health and Higher Education, and 5 years inside the French Embassy in Riyadh as Regional Health Counsellor, with 23 signed bilateral agreements and €3.2bn in cumulative contract value.
- Long-term strategic positioning in KSA, UAE, Qatar
- Engagement with Ministries of Health, Saudi FDA, sovereign hospital groups
- Public-private partnership structuring (PPP)
- Localization and Vision 2030 alignment